Abstract:Accurate diagnosis of the initial phase of Alzheimer's disease (AD) is essential and crucial. The objective of this research was to employ efficient biomarkers for the diagnostic analysis and classification of AD based on combining structural MRI (sMRI) and resting-state functional MRI (rs-fMRI). So far, several anatomical MRI imaging markers for AD diagnosis have been identified. The use of cortical and subcortical volumes, the hippocampus, and amygdala volume, as well as genetic patterns, has proven to be beneficial in distinguishing patients with AD from the healthy population. The fMRI time series data have the potential for specific numerical information as well as dynamic temporal information. Voxel and graphical analyses have gained popularity for analyzing neurodegenerative diseases, such as Alzheimer's and its prodromal phase, mild cognitive impairment (MCI). So far, these approaches have been utilized separately for the diagnosis of AD. In recent studies, the classification of cases of MCI into those that are not converted for a certain period as stable MCI (MCIs) and those that converted to AD as MCIc has been less commonly reported with inconsistent results. In this study, we verified and validated the potency of a proposed diagnostic framework to identify AD and differentiate MCIs from MCIc by utilizing the efficient biomarkers obtained from sMRI, along with functional brain networks of the frequency range .01-.027 at the resting state and the voxel-based features. The latter mainly included default mode networks (amplitude of low-frequency fluctuation [ALFF], fractional ALFF [ALFF], and regional homogeneity [ReHo]), degree centrality (DC), and salience networks (SN). Pearson's correlation coefficient for measuring fMRI functional networks has proven to be an efficient means for disease diagnosis. We applied the graph theory to calculate nodal features (nodal degree [ND], nodal path length [NL], and between centrality [BC]) as a graphical feature and analyzed the connectivity link between different brain regions. We extracted three-dimensional (3D) patterns to calculate regional coherence and then implement a univariate statistical t-test to access a 3D mask that preserves voxels showing significant changes. Similarly, from sMRI, we calculated the hippocampal subfield and amygdala nuclei volume using Freesurfer (version 6). Finally, we implemented and compared the different feature selection algorithms to integrate the structural features, brain networks, and voxel features to optimize the diagnostic identifications of AD using support vector machine (SVM) classifiers. We also compared the performance of SVM with Random Forest (RF) classifiers. The obtained results demonstrated the potency of our framework, wherein a combination of the hippocampal subfield, the amygdala volume, and brain networks with multiple measures of rs-fMRI could significantly enhance the accuracy of other approaches in diagnosing AD. The accuracy obtained by the proposed method was reported for binary classification. More importantly, the classification results of the less commonly reported MCIs vs. MCIc improved significantly. However, this research involved only the AD Neuroimaging Initiative (ADNI) cohort to focus on the diagnosis of AD advancement by integrating sMRI and fMRI. Hence, the study's primary disadvantage is its small sample size. In this case, the dataset we utilized did not fully reflect the whole population. As a result, we cannot guarantee that our findings will be applicable to other populations.

Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI

Predicting conversion from MCI to AD by integrating rs-fMRI and structural MRI

Predicting conversion from MCI to AD using resting-state fMRI, graph theoretical approach and SVM

Alzheimer's Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural MRI

Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using MRI and Structural Network Features.

Predicting MCI to AD Conversation Using Integrated sMRI and rs-fMRI: Machine Learning and Graph Theory Approach

Application of advanced machine learning methods on resting-state fMRI network for identification of mild cognitive impairment and Alzheimer’s disease

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using Graph Frequency Bands and Functional Connectivity-Based Features

Effective and Accurate Diagnosis of Subjective Cognitive Decline Based on Functional Connection and Graph Theory View.

Prediction of conversion from amnestic mild cognitive impairment to alzheimer’s disease based on brain structural connectome

Identification Of Conversion From Mild Cognitive Impairment To Alzheimer'S Disease Using Multivariate Predictors

Quantitative Assessment of Resting‐State Functional Connectivity MRI to Differentiate Amnestic Mild Cognitive Impairment, Late‐Onset Alzheimer's Disease From Normal Subjects

Structural, static, and dynamic functional MRI predictors for conversion from mild cognitive impairment to Alzheimer's disease: Inter-cohort validation of Shanghai Memory Study and ADNI

Brain Connectivity Based Prediction of Alzheimer’s Disease in Patients with Mild Cognitive Impairment Based on Multi-Modal Images

Transferable Structural, Static and Dynamic Functional MRI Features for Predicting Conversion from Mild Cognitive Impairment to Alzheimer’s Disease in Shanghai Memory Study and ADNI Cohorts

Temporal and Spatial Analysis of Alzheimer’s Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network

Predicting conversion from MCI to AD by integration of rs-fMRI and clinical information using 3D-convolutional neural network

Identifying discriminative features of brain network for prediction of Alzheimer's disease using graph theory and machine learning

Machine learning based on functional and structural connectivity in mild cognitive impairment

Classification of patients with MCI and AD from healthy controls using directed graph measures of resting-state fMRI

Prediction of Alzheimer's Disease Using Individual Structural Connectivity Networks